Literature DB >> 10655988

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

A Harris1, G Chang, M Vadas, D Gillis.   

Abstract

BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCA) have been used as a diagnostic marker for systemic necrotising vasculitis, a disease classification which includes Wegener granulomatosis, microscopic and classic polyarteritis nodosa, and Churg Strauss disease.
OBJECTIVE: To compare the diagnostic value of the two methods for detecting these antibodies--immunofluorescence and enzyme linked immunosorbent assay (ELISA)--with respect to biopsy proven active systemic necrotising vasculitis in a clinically relevant population.
METHODS: A prospective study to ascertain the patient's diagnosis at the time of each of the 466 requests for ANCA received at one laboratory over a nine month period, and allocate each to one of five diagnostic groups: active and inactive biopsy proven systemic necrotising vasculitis, suspected systemic necrotising vasculitis, low probability systemic necrotising vasculitis, and not systemic necrotising vasculitis.
RESULTS: ELISA was superior to immunofluorescence in the diagnosis of systemic necrotising vasculitis because it was less likely to detect other diseases. This was reflected in its specificity of 97% and positive predictive value of 73%, compared with 90% and only 50% for immunofluorescence (p = 0.0006 and p = 0.013, respectively). ELISA had a negative predictive value of 98% which was not significantly different to immunofluorescence. ELISA was technically superior.
CONCLUSIONS: ELISA is the superior method of ANCA detection in the diagnosis of systemic necrotising vasculitis and should be used in conjunction with a compatible clinical picture and histological evidence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10655988      PMCID: PMC501542          DOI: 10.1136/jcp.52.9.670

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

2.  Rapid method for the isolation of neutrophils in high yield without the use of dextran or density gradient polymers.

Authors:  P Eggleton; R Gargan; D Fisher
Journal:  J Immunol Methods       Date:  1989-07-06       Impact factor: 2.303

3.  Wegener's granulomatosis: studies in eighteen patients and a review of the literature.

Authors:  A S Fauci; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

4.  Classification and treatment of systemic vasculitis.

Authors:  D G Scott
Journal:  Br J Rheumatol       Date:  1988-08

5.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

6.  Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.

Authors:  J W Tervaert; P C Limburg; J D Elema; M G Huitema; G Horst; T H The; C G Kallenberg
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

7.  Cyclophosphamide therapy of severe systemic necrotizing vasculitis.

Authors:  A S Fauci; P Katz; B F Haynes; S M Wolff
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

8.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

9.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  5 in total

1.  Photodynamic treatment of pooled coumarin plasma for external quality assessment of the prothrombin time.

Authors:  A M van den Besselaar; A C Moor
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

Review 2.  Endocarditis associated with antineutrophil cytoplasmic antibodies: a case report and review of the literature.

Authors:  Julio A Chirinos; Vicente F Corrales-Medina; Santiago Garcia; Daniel M Lichtstein; Alan L Bisno; Simon Chakko
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

3.  Double ANCA-positive vasculitis in a patient with infective endocarditis.

Authors:  I Veerappan; E N Prabitha; A Abraham; S Theodore; G Abraham
Journal:  Indian J Nephrol       Date:  2012-11

Review 4.  Laboratory testing in the evaluation and diagnosis of vasculitis.

Authors:  M L Cuellar; L R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

5.  Comparison between enzyme-linked immunosorbent assay and indirect immunofluorescence for detection of antineutrophil cytoplasmic antibodies.

Authors:  Julia Miranda Menezes; Raissa Rossener; Ana Paula Marques Aguirra da Silva; Silvia Sanches Rodrigues; Cristóvão Luis Pitangueira Mangueira
Journal:  Einstein (Sao Paulo)       Date:  2020-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.